≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Malignant neoplasm of penis

DOID Endpoint Browser

C3_PENIS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

only males

244368

2. Check conditions

None

244368

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C60
  • Cause of death: ICD-9 — 187[1-4]
  • Cause of death: ICD-8 — 1870
  • Cancer registry: Topography ICD-O-3 — C60
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

152

4. Check minimum number of events

None

152

5. Include endpoints

None

152

6. Filter based on genotype QC (FinnGen only)

135

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 135 - 135
Unadjusted period prevalence (%) 0.06 - 0.06
Median age at first event (years) 65.66 - 65.66

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
144
Matched controls
1440
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
+∞
126.3
102
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
62.9
81.3
47
11
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
+∞
77.2
67
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
69.5
61
*
8070/3-C60.9
ICD-O-3
Squamous cell carcinoma, NOS, of penis, NOS
+∞
58.4
52
*
KGC00
NOMESCO Finland
Partial amputation of penis
+∞
55.9
50
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
45.2
41
*
KGB00
NOMESCO Finland
Biopsy of penis
579.0
44.8
42
*
JN4AD
NOMESCO Finland
Body CT examination
15.1
44.0
45
42
KGH10
NOMESCO Finland
Operation for phimosis
15.0
43.0
44
41
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
+∞
42.9
39
*
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
+∞
41.7
38
*
8070/3-C60.1
ICD-O-3
Squamous cell carcinoma, NOS, of glans penis
+∞
41.7
38
*
130
Kela drug reimbursment
Malignant tumour
+∞
38.2
35
*
WX402
NOMESCO Finland
General anaesthesia
8.8
37.8
69
136
N48.1
ICD-10 Finland
Balanoposthitis
17.5
36.9
33
24
JN4BD
NOMESCO Finland
Extensive body CT
15.2
36.6
36
31
KGD00
NOMESCO Finland
Partial excision of glans penis
+∞
32.5
30
*
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
11.1
31.1
38
45
C61
ICD-10 Finland
Malignant neoplasm of prostate
360.7
30.0
29
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
29.2
27
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
26.9
25
*
Z51.5
ICD-10 Finland
Palliative care
12.2
25.6
28
28
KGD05
NOMESCO Finland
Partial excision of body of penis
+∞
24.7
23
*
H02AB02
ATC
dexamethasone; systemic
62.9
23.0
26
5
A03FA01
ATC
metoclopramide; systemic, rectal
8.3
22.4
34
52
WF002
NOMESCO Finland
Radical radiotherapy
+∞
21.4
20
*
UKC02
NOMESCO Finland
Cystoscopy
5.4
20.7
56
151
C60.2
ICD-10 Finland
Malignant neoplasm: Body of penis
+∞
20.3
19
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
20.3
19
*
KGD96
NOMESCO Finland
Other partial excision of penis
+∞
20.3
19
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
19.2
18
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.6
18.3
29
46
C60.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of penis
+∞
18.1
17
*
116
Kela drug reimbursment
Prostate cancer
+∞
18.1
17
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
6.4
17.8
34
66
B01AB10
ATC
tinzaparin; parenteral
7.5
17.5
28
45
ZXE10
NOMESCO Finland
More than one and less than three hours
4.3
16.8
74
285
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
38.3
16.2
20
6
XKD00
NOMESCO Finland
Uroflowmetry
4.1
14.4
57
200
WZC00
NOMESCO Finland
Treatment plan or consultation
3.9
14.0
59
216
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.0
13.8
54
187
KGC10
NOMESCO Finland
Total amputation of penis
+∞
13.8
13
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
13.8
13
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
13.8
13
*
ZZA00
NOMESCO Finland
Split skin graft
15.1
12.9
21
16
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
+∞
12.7
12
*
KDH10
NOMESCO Finland
Meatoplasty of urethra
141.8
12.6
13
*
TKD00
NOMESCO Finland
Dilatation of urethra
51.3
12.1
14
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.6
11
*
D07.4
ICD-10 Finland
Carcinoma in situ: Penis
+∞
11.6
11
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
11.6
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
130.0
11.6
12
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.3
11.5
26
58
WX408
NOMESCO Finland
General anesthesy, balanced
3.6
11.5
52
196
XX3DW
NOMESCO Finland
Time consuming IT work
9.8
11.0
22
26
N48.9
ICD-10 Finland
Disorder of penis, unspecified
64.9
10.8
12
*
L03AA02
ATC
filgrastim; parenteral
118.3
10.6
11
*
WZC30
NOMESCO Finland
Teaching
4.0
10.5
35
106
8070/3-C60.0
ICD-O-3
Squamous cell carcinoma, NOS, of prepuce
+∞
10.5
10
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
10.5
10
*
L02BB03
ATC
bicalutamide; oral
+∞
10.5
10
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
10.5
10
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
10.5
10
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
10.5
10
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
6.0
10.4
20
38
TKC20
NOMESCO Finland
Catheterisation of bladder
4.8
9.6
24
58
WX240
NOMESCO Finland
Penis blockade
32.5
9.6
12
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
9.5
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.5
9
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.1
9.4
29
83
N02AA05
ATC
oxycodone; systemic
3.7
9.1
34
111
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
13.8
9.1
15
12
A04AA01
ATC
ondansetron; systemic, rectal
15.3
8.9
14
10
WX320
NOMESCO Finland
Spinalanesthesy
3.0
8.7
50
214
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
95.4
8.5
9
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
8.4
8
*
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
18.5
8.2
12
7
N48.8
ICD-10 Finland
Other specified disorders of penis
18.5
8.2
12
7
KGD10
NOMESCO Finland
Destruction of lesion of penis
35.5
8.2
10
*
JN4CD
NOMESCO Finland
Very extensive body CT
23.6
8.1
11
5
R33
ICD-10 Finland
Retention of urine
3.5
8.1
32
108
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.0
8.1
26
76
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
47.6
7.8
9
*
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
12.8
7.7
13
11
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
10.9
7.7
14
14
L03AA13
ATC
pegfilgrastim; parenteral
84.2
7.5
8
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
7.3
7
*
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
7.3
7
*
C60
ICD-10 Finland
Malignant neoplasm of penis
+∞
7.3
7
*
KGW96
NOMESCO Finland
Other operation on penis
+∞
7.3
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
8051/3-C60.9
ICD-O-3
Verrucous carcinoma, NOS, of penis, NOS
+∞
7.3
7
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
+∞
7.3
7
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
N35.9
ICD-10 Finland
Urethral stricture, unspecified
13.0
7.2
12
10
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.4
7.0
16
24
ZXE20
NOMESCO Finland
More than three and less than five hours
3.3
7.0
31
112
B01AB05
ATC
enoxaparin; parenteral
2.7
6.9
52
253
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
72.9
6.5
7
*
J01EA01
ATC
trimethoprim; systemic
3.4
6.4
25
83
J01DB01
ATC
cefalexin; oral
3.3
6.4
123
923
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
19.0
6.3
9
5
ZX120
NOMESCO Finland
Intravenous
4.1
6.3
18
48
QBA10
NOMESCO Finland
Incision of skin of trunk
28.0
6.3
8
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
6.3
6
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
C609, 8086, 3
ICD-O-3
+∞
6.3
6
*
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
KGA10
NOMESCO Finland
Incision of prepuce
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
8051/3-C60.1
ICD-O-3
Verrucous carcinoma, NOS, of glans penis
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
S18
ICPC
Laceration/cut
2.4
6.3
77
465
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
6.0
24
81

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
52
26
30.74
71.23
1.8
1.2
—
—
—
0
0
58
81
11.32
42.95
1.5
1.1
—
—
—
0
0
92
272
7.60
33.16
3.6
1.6
—
—
—
0
0
105
465
5.65
21.07
3.6
2.4
—
—
estimate
—
0
0
51
133
5.39
19.50
2.0
1.8
—
—
—
0
0
70
249
4.52
17.97
2.9
2.7
—
—
—
0
0
80
332
4.17
16.26
3.1
2.2
—
—
—
0
0
117
662
5.09
14.86
6.5
3.6
20.83
405.56
e6/l
—
6
9
22
34
7.46
14.09
1.9
1.3
—
—
—
0
0
66
269
3.68
13.20
1.7
1.3
—
—
—
0
0
73
358
3.11
10.22
5.2
3.8
—
—
—
0
0
58
262
3.03
9.20
5.0
3.5
85.59
83.53
%
0.21
58
257
45
190
2.99
7.89
4.2
2.7
0.74
0.51
e6/l
0.34
24
97
116
821
3.12
7.15
12.3
5.9
81.99
75.82
u/l
0.86
111
772
44
193
2.84
7.13
2.3
1.8
—
—
—
0
0
68
372
2.57
7.09
5.1
2.8
22.08
235.42
e6/l
0.63
53
278
93
595
2.59
6.89
16.9
17.6
1.28
1.36
inr
0.74
80
494
70
403
2.43
6.38
5.8
3.3
838.59
100.63
e6/l
0.47
56
288
56
299
2.43
5.95
4.0
2.6
—
0.00
estimate
—
0
5
58
320
2.36
5.68
4.4
2.7
0.38
0.31
e6/l
0.15
42
229
43
208
2.52
5.61
2.5
1.7
29.97
29.56
s
0.28
43
200
26
98
3.02
5.44
1.3
1.4
—
—
—
0
0
83
545
2.23
5.25
9.1
6.7
1.20
1.20
mmol/l
0.08
71
481
19
61
3.44
5.13
1.1
1.6
—
—
—
0
0
61
357
2.23
5.09
8.4
5.4
—
—
—
0
0
39
188
2.47
5.08
8.3
7.1
104.95
104.27
mmol/l
0.73
39
188
74
485
2.08
4.48
8.6
6.3
1.20
1.20
mmol/l
0.09
69
446
86
599
2.08
4.38
16.5
6.4
4.62
4.44
e9/l
0.25
78
524
8
11
7.62
3.91
2.3
1.4
143.50
3.14
u/ml
—
8
11
14
39
3.86
3.82
2.8
1.7
—
—
—
0
0
23
98
2.60
3.81
1.2
1.6
—
—
—
0
0
50
298
2.04
3.79
5.1
3.7
7.40
7.39
ph
0.07
36
214
27
125
2.43
3.78
1.3
1.6
—
—
—
0
0
67
444
1.95
3.75
4.4
3.0
6.18
6.12
ph
0.15
44
256
71
486
1.91
3.56
14.4
9.9
0.00
0.00
e9/l
0.49
60
402
110
874
2.10
3.52
31.9
17.8
14.05
13.59
%
2.62
110
862
24
116
2.28
3.04
9.8
9.7
—
—
—
0
0
48
306
1.85
2.88
3.8
2.8
0.00
0.00
estimate
—
10
76
29
158
2.05
2.74
5.2
1.7
1.58
1.61
%
0.11
29
136
76
564
1.74
2.69
4.4
3.2
93.53
0.00
estimate
0.48
17
104
77
575
1.73
2.65
4.5
3.2
0.00
0.04
estimate
0.49
15
92
75
560
1.71
2.56
4.4
3.2
0.00
0.00
estimate
-0.00
15
105
74
556
1.68
2.43
9.6
5.6
1.81
1.82
e9/l
0.01
65
489
129
1140
2.26
2.40
32.0
19.3
139.27
139.73
mmol/l
1.45
129
1119
73
550
1.66
2.34
9.6
5.5
0.70
0.63
e9/l
1.43
63
472
73
550
1.66
2.34
9.6
5.5
0.04
0.04
e9/l
0.02
62
477
129
1145
2.22
2.28
32.9
19.3
4.02
4.05
mmol/l
0.64
129
1123
51
355
1.68
2.19
1.5
1.7
15.75
18.57
nmol/l
0.98
44
302
7
19
3.82
2.18
1.0
1.2
—
—
—
0
0
73
562
1.61
2.07
10.0
5.5
0.27
0.23
e9/l
0.31
64
493
9
35
2.67
1.83
2.2
2.4
1.71
1.84
mg/l
—
9
30
18
96
2.00
1.80
2.6
1.9
66.67
66.82
g/l
0.02
18
88
43
301
1.61
1.76
10.3
4.6
—
—
—
0
0
26
159
1.78
1.74
9.0
7.9
7.42
7.42
ph
—
8
92
129
1177
1.92
1.61
38.9
20.3
90.02
90.77
umol/l
0.08
129
1166
5
15
3.41
1.53
1.4
1.3
0.76
0.80
%
—
5
9
6
21
2.93
1.52
1.7
1.4
—
—
—
0
0
33
225
1.61
1.49
1.8
1.9
1077.39
1206.38
nmol/l
0.38
26
180
67
544
1.43
1.31
2.3
2.1
88.15
90.73
pmol/l
0.17
46
302
5
18
2.84
1.29
1.6
2.4
2.90
1.81
g/24h
—
5
12
15
85
1.85
1.28
3.3
4.2
0.00
0.00
%
—
6
18
14
80
1.83
1.18
3.4
4.0
0.00
0.06
%
—
5
18
55
438
1.41
1.17
4.5
3.3
0.00
0.00
estimate
-0.00
13
81
5
20
2.55
1.16
3.2
1.2
—
—
—
0
0
21
138
1.61
1.10
2.0
1.5
—
—
—
0
0
33
241
1.48
1.10
1.3
1.6
1.70
1.08
mg/l
0.68
28
184
5
22
2.32
1.04
1.6
1.3
—
—
—
0
0
14
84
1.74
1.02
3.4
3.9
0.40
0.82
%
—
5
22
128
1201
1.59
0.95
42.5
22.4
92.14
91.59
fl
0.59
128
1184
15
94
1.67
0.95
1.9
2.2
0.22
0.21
g/l
0.07
15
78
128
1202
1.58
0.93
42.3
22.3
30.56
30.69
pg
0.30
128
1185
128
1202
1.58
0.93
43.4
23.0
39.79
41.68
%
3.52
128
1186
128
1202
1.58
0.93
42.7
22.5
131.31
140.69
g/l
6.06
128
1186
13
79
1.71
0.91
3.2
1.4
—
—
—
0
0
123
1148
1.49
0.90
21.4
13.5
—
—
—
0
0
13
80
1.69
0.88
1.5
4.0
1.20
0.27
%
—
5
22
6
32
1.91
0.82
3.0
4.1
—
—
—
0
0
117
1090
1.39
0.78
5.1
5.3
6.27
6.17
mmol/l
0.43
111
986
5
24
2.12
0.75
3.6
2.7
—
—
—
0
0
5
24
2.12
0.75
1.0
1.1
—
—
—
0
0
7
39
1.83
0.73
1.4
1.1
1.34
1.43
g/l
—
7
39
7
42
1.70
0.69
1.4
1.5
—
—
—
0
0
98
901
1.27
0.65
6.1
4.1
2.06
1.92
ug/l
0.25
91
807
14
97
1.49
0.61
2.9
1.5
389.57
401.14
nmol/l
0.07
14
86
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
5
88
0.55
0.58
6.2
4.2
—
—
—
0
0
52
452
1.24
0.54
3.6
3.9
—
—
—
0
0
11
77
1.46
0.47
4.5
2.7
—
—
—
0
0
15
112
1.38
0.47
2.0
1.5
—
—
—
0
0
8
57
1.43
0.43
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
5
79
0.62
0.36
2.2
2.3
0.84
0.58
%
—
5
79
58
528
1.16
0.35
3.9
4.2
41.27
50.68
ng/l
0.32
48
415
12
153
0.76
0.32
1.0
1.2
0.87
5.55
u/ml
—
6
56
43
474
0.87
0.29
2.1
2.1
1.76
1.38
mmol/l
1.54
34
398
9
77
1.18
0.25
6.6
3.2
—
—
—
0
0
6
81
0.73
0.25
3.0
2.4
1.50
1.19
%
—
6
81
115
1116
1.15
0.23
5.3
5.5
4.37
4.35
mmol/l
0.08
106
1039
36
326
1.14
0.23
5.2
3.4
0.00
0.03
estimate
0.50
15
96
13
107
1.24
0.22
1.6
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
7.84
—
0
5
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
1.97
—
0
11
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
3.52
—
0
6
6
48
1.26
0.20
1.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
2.0
—
485.86
—
0
7
44
466
0.92
0.14
3.3
3.5
—
—
—
0
0
116
1139
1.09
0.12
5.2
6.3
2.49
2.55
mmol/l
0.26
106
1057
13
147
0.87
0.12
1.2
1.2
—
—
—
0
0
113
1112
1.08
0.09
4.8
5.4
1.24
1.31
mmol/l
1.33
102
1026
5
62
0.80
0.08
1.0
1.1
—
—
—
0
0
10
88
1.15
0.08
5.4
3.0
—
—
—
0
0
6
74
0.80
0.08
6.0
3.0
27.67
25.39
mmol/l
—
6
69
8
74
1.09
0.07
1.3
1.2
822.00
475.57
u/ml
—
8
69
9
101
0.88
0.06
1.8
1.4
—
—
—
0
0
54
525
1.05
0.06
3.0
2.8
0.79
0.80
ug/l
0.05
38
330
24
228
1.06
0.05
7.0
4.0
—
—
—
0
0
108
1093
0.95
0.05
6.5
7.3
41.52
40.47
mmol/mol
0.58
98
1021
16
150
1.07
0.04
4.1
3.3
7.38
7.39
ph
0.10
11
93
109
1079
1.04
0.04
4.7
4.5
1.49
1.35
mmol/l
1.24
100
989
94
929
1.03
0.03
36.4
18.7
330.90
334.54
g/l
2.81
94
921
77
760
1.03
0.03
3.1
3.1
14.61
14.98
pmol/l
0.67
72
677
100
991
1.03
0.02
3.6
4.1
1.82
2.01
mu/l
1.04
89
887
48
474
1.02
0.00
4.3
4.5
12.82
11.62
mg/mmol
0.07
36
328
47
467
1.01
0.00
3.4
3.7
7.67
8.56
mmol/l
0.73
42
402
46
456
1.01
0.00
3.4
3.8
82.67
73.46
mg/l
0.08
36
325
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
6
60
1.00
0.00
1.0
1.2
—
19.33
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
32.88
—
0
5
0
7
0.00
-0.00
0.0
1.9
—
4.77
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
197.71
—
0
7
0
7
0.00
-0.00
0.0
15.7
—
1630.00
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
19.11
—
0
9
0
9
0.00
-0.00
0.0
1.0
—
27.33
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.00
—
0
5
0
7
0.00
-0.00
0.0
14.1
—
1073.86
—
0
7
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
164.80
—
0
8
0
5
0.00
-0.00
0.0
8.6
—
0.55
—
0
5
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1394.00
—
0
5
0
7
0.00
-0.00
0.0
1.9
—
2.03
—
0
7
0
8
0.00
-0.00
0.0
1.3
—
193.75
—
0
8
0
9
0.00
-0.00
0.0
1.1
—
76.33
—
0
9
0
7
0.00
-0.00
0.0
1.4
—
87.46
—
0
7
6
66
0.91
-0.00
1.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
86.13
—
0
8
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_PENIS – Malignant neoplasm of penis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).